CTL: Caspases Terminate Life, but that's not the whole story

被引:22
作者
Waterhouse, NJ [1 ]
Trapani, JA [1 ]
机构
[1] Peter MacCallum Canc Inst, Div Res, Canc Immunol Lab, Melbourne, Australia
来源
TISSUE ANTIGENS | 2002年 / 59卷 / 03期
关键词
D O I
10.1034/j.1399-0039.2002.590301.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The induction of cell death by cytotoxic T-lymphocytes (CTL) or natural killer M cells is one of the main ways by which higher organisms protect themselves from rogue cells, including those infected by a virus, or posing a risk of cancer. Considering the rapidity of viral replication and spread to uninfected cells, CTL and NK are extremely efficient killers. This is at least partly due to the variety of pathways that these cytolytic lymphocytes (CL) can use to ensure the death of a cell, CL utilize two independently initiated pathways involving either Primarily, ligation of death receptors or perforin mediated trafficking of granzyme B to the target cell cytosol to activate a family of death proteases (caspases) in the target cell. The caspases then orchestrate the orderly dismantling of that cell by cleavage of a set of critical substrates. If caspases are inactivated, due either to mutations in proteins that signal their activation or direct CL can utilize a caspase-independent inhibition by a viral gene product, pathway to ensure the death of the target cell. Here we will discuss the mechanisms by which these stellar killers achieve their goal.
引用
收藏
页码:175 / 183
页数:9
相关论文
共 48 条
  • [1] Anti-apoptotic oncogenes prevent caspase-dependent and independent commitment for cell death
    Amarante-Mendes, GP
    Finucane, DM
    Martin, SJ
    Cotter, TG
    Salvesen, GS
    Green, DR
    [J]. CELL DEATH AND DIFFERENTIATION, 1998, 5 (04) : 298 - 306
  • [2] Granzyme A loading induces rapid cytolysis and a novel form of DNA damage independently of caspase activation
    Beresford, PJ
    Xia, ZN
    Greenberg, AH
    Lieberman, J
    [J]. IMMUNITY, 1999, 10 (05) : 585 - 594
  • [3] The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites
    Bladergroen, BA
    Strik, MCM
    Bovenschen, N
    van Berkum, O
    Scheffer, GL
    Meijer, CJLM
    Hack, CE
    Kummer, JA
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (05) : 3218 - 3225
  • [4] Recruitment, activation and retention of caspases-9 and-3 by Apaf-1 apoptosome and associated XIAP complexes
    Bratton, SB
    Walker, G
    Srinivasula, SM
    Sun, XM
    Butterworth, M
    Alnemri, ES
    Cohen, GM
    [J]. EMBO JOURNAL, 2001, 20 (05) : 998 - 1009
  • [5] Browne KA, 1999, MOL CELL BIOL, V19, P8604
  • [6] Comparative modeling of amoebapores and granulysin based on the NK-lysin structure - Structure and functional implications
    Bruhn, H
    Leippe, M
    [J]. BIOLOGICAL CHEMISTRY, 1999, 380 (7-8) : 1001 - 1007
  • [7] Dependence of granzyme B-mediated cell death on a pathway regulated by Bcl-2 or its viral homolog, BHRF1
    Davis, JE
    Sutton, VR
    Smyth, MJ
    Trapani, JA
    [J]. CELL DEATH AND DIFFERENTIATION, 2000, 7 (10) : 973 - 983
  • [8] Davis JE, 2001, EUR J IMMUNOL, V31, P39, DOI 10.1002/1521-4141(200101)31:1<39::AID-IMMU39>3.0.CO
  • [9] 2-1
  • [10] Functional avidity of tumor antigen-specific CTL recognition directly correlates with the stability of MHC/peptide multimer binding to TCR
    Dutoit, V
    Rubio-Godoy, V
    Doucey, MA
    Batard, P
    Liénard, D
    Rimoldi, D
    Speiser, D
    Guillaume, P
    Cerottini, JC
    Romero, P
    Valmori, D
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (03) : 1167 - 1171